Search Result "histamine H<sub>4</sub>R affinity"
Discovery of Novel Lead in the Group of N-substituted Piperazine Ether Derivatives with Potential Histamine H3 Receptor Activity
Journal: Medicinal Chemistry
Volume: 10 Issue: 6 Year: 2014 Page: 588-599
Author(s): Kamil J. Kuder, Marta Stachnik, Walter Schunack, Ewa Szyman ska, Katarzyna Kiec -Kononowicz
Histamine H4 Receptor Antagonists: A New Approach for Tinnitus Treatment?
Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 10 Issue: 1 Year: 2015 Page: 6-9
Author(s): Jens Hagenow,Holger Stark
Immunosuppression in Liver Transplantation
Journal: Current Drug Targets
Volume: 10 Issue: 6 Year: 2009 Page: 557-574
Author(s): Sandeep Mukherjee, Jean F. Botha, Urmila Mukherjee
G Protein-Coupled Receptor Signaling Complexity in Neuronal Tissue:Implications for Novel Therapeutics
Journal: Current Alzheimer Research
Volume: 4 Issue: 1 Year: 2007 Page: 3-19
Author(s): Stuart Maudsley, Bronwen Martin, Louis M. Luttrell
Drug Design of GPCR Ligands Using Physicogenetics and Chemogenomics - Principles and Case Studies
Journal: Current Topics in Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2011 Page: 1882-1901
Author(s): Thomas M. Frimurer, Thomas Hogberg
Design of Protective and Therapeutic DNA Vaccines for the Treatment of Allergic Diseases
Journal: Current Drug Targets - Inflammation & Allergy
Volume: 4 Issue: 5 Year: 2005 Page: 585-597
Author(s): Richard Weiss, Peter Hammerl, Arnulf Hartl, Romana Hochreiter, Wolfgang W. Leitner, Sandra Scheiblhofer, Josef Thalhamer
Central G-Protein Coupled Receptors (GPCR)s as Molecular Targets for the Treatment of Obesity: Assets, Liabilities and Development Status
Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 3 Issue: 5 Year: 2004 Page: 357-377
Author(s): Keith J. Miller, Brian J. Murphy, Mary Ann Pelleymounter
Multi-functional Ligands and Molecular Hybridization: Conceptual Aspects and Application in the Innovative Design of Drug Candidate Prototypes for Neurodegenerative Diseases
Ebook: Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Volume: 11 Year: 2023
Author(s):
Doi: 10.2174/9789815123319123110003
Strategies to Convert PACAP from a Hypophysiotropic Neurohormone Into a Neuroprotective Drug
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 1 Year: 2011 Page: 1002-1024
Author(s): S. Bourgault, D. Chatenet, O. Wurtz, N. D. Doan, J. Leprince, H. Vaudry, A. Fournier, D. Vaudry
Anti-Inflammatory Drugs in the Treatment of Neurodegenerative Diseases: Current State
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 2 Year: 2006 Page: 3509-3519
Author(s): Yossi Gilgun-Sherki, Eldad Melamed, Daniel Offen